2010

2010

2010

April 18, 2010

“Good” cells can go “bad” in a “bad neighborhood"

March 22, 2010

The general theory of cancer development holds that malignancies occur because of the presence of certain genetic elements within the affected cells.

But a new study by Harvard researchers at Massachusetts General Hospital (MGH) indicates that “good” cells can become cancerous because of exposure to a “bad” environment within the body — similarly to the way a “good boy” may turn to crime when exposed to the pressures of life in a crime-ridden neighborhood.

Leukemia pathway identified that suggests targets for therapy

April 16, 2010

Acute myelogenous leukemia (AML) is one of the most common types of leukemia—a cancer of the bone marrow and blood—in adults, affecting about 13,300 women and men in the United States annually. The disease is also diagnosed in hundreds of children in this country each year.

HSCI call for proposals - Kidney Program pilot grants

April 22, 2010

The Harvard Stem Cell Institute (HSCI) Kidney Program invites applications for Pilot Grant funding for 2010. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of kidney stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high- impact research projects that could fundamentally enhance biomedical research around proximal tubule associated components of the kidney.

HSCI call for proposals - Cancer Program pilot grants

May 4, 2010

The Harvard Stem Cell Institute (HSCI) Cancer Program invites applications for Pilot Grant funding for 2010. The purpose of this funding program is to provide resources for innovative projects by investigators in the field of cancer stem cell biology, including basic, translational or clinical research. This funding is for groundbreaking, innovative, high- impact research projects that could fundamentally enhance biomedical research.  Particularly welcomed are applications that promote the Program mission: to identify critical genes and pathways that sufficiently distinguish cancer from normal stem cells and hence serve as candidate targets for therapy.

David Scadden, MD, and Leonard I. Zon, MD, win Hematology Society awards

July 22, 2010

"The American Society of Hematology (ASH), the world’s largest professional society of blood specialists, will honor six scientists who have made significant contributions to the understanding and treatment of hematologic diseases. These awards will be presented at the 52nd ASH Annual Meeting taking place December 4-7 in Orlando."

Two HSCI Principal Faculty members are among those receiving awards.

Pages